Betamethasone latency period and neonatal hypoglycemia in term infants
Introduction Infants exposed to antenatal betamethasone (BMZ) between 34.0 and 36.6 weeks gestational age (GA) have increased risk for neonatal hypoglycemia, a known cause of brain injury. While a shorter latency period between BMZ administration and delivery is associated with an increased risk of...
Saved in:
| Main Authors: | Lauren A. Buckley, Briana Clifton, Katelyn M. Tessier, Connor Demorest, Raghavendra B. Rao, Sarah A. Wernimont |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | The Journal of Maternal-Fetal & Neonatal Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/14767058.2025.2540477 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antenatal corticosteroid treatment after 34 weeks of gestation in twin pregnancies at high risk of late preterm delivery
by: Murat Levent Dereli, et al.
Published: (2025-03-01) -
Rescue Antenatal Corticosteroids in Late Preterm Birth after Completion of the Initial Cycle of Antenatal Corticosteroids during the Early Preterm Period
by: Da Eun Jeong, et al.
Published: (2023-10-01) -
General health and social outcomes 50 years after exposure to antenatal betamethasone: follow-up of a randomised controlled trial
by: Anthony G. B. Walters, et al.
Published: (2024-11-01) -
Cushing’s syndrome in a young woman due to prolonged betamethasone nasal drop use: a case report
by: Mohammadsadra Shamohammadi, et al.
Published: (2025-07-01) -
The Influence of Moisturizer Co-Application Protocols on In Vitro Penetration of Betamethasone in Porcine Skin
by: Daiane L. Rost, et al.
Published: (2025-07-01)